SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001193125-04-012126
Filing Date
2004-01-30
Accepted
2004-01-30 17:08:00
Documents
6

Document Format Files

Seq Description Document Type Size
1 FORM S-3/A AMENDMENT #2 ds3a.htm S-3/A 333774
3 OPINION OF ROPES & GRAY LLP. dex51.htm EX-5.1 5324
4 CONSENT OF ERNST & YOUNG LLP, ON GENOME THERAPEUTICS CORP. dex231.htm EX-23.1 1700
5 CONSENT OF ERNST & YOUNG LLP, ON GENESOFT PHARMACEUTICALS, INC. dex232.htm EX-23.2 1821
6 PLACEMENT AGENT AGREEMENT dex991.htm EX-99.1 321864
7 GRAPHIC g84887g24r93.jpg GRAPHIC 23094
  Complete submission text file 0001193125-04-012126.txt   689802
Mailing Address 100 BEAVER STREET WALTHAM MA 02453
Business Address 1OO BEAVER ST WALTHAM MA 02453 7813982300
GENOME THERAPEUTICS CORP (Filer) CIK: 0000356830 (see all company filings)

IRS No.: 042297484 | State of Incorp.: MA | Fiscal Year End: 0831
Type: S-3/A | Act: 33 | File No.: 333-111273 | Film No.: 04556688
SIC: 2835 In Vitro & In Vivo Diagnostic Substances